We can’t show the full text here under this license. Use the link below to read it at the source.
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Guidelines for Managing High Blood Sugar in Type 2 Diabetes, 2018
AI simplified
Abstract
New recommendations for managing type 2 diabetes emphasize lifestyle changes and specific medications based on patient conditions.
- Lifestyle management and diabetes self-management education are prioritized updates in the approach to type 2 diabetes.
- Weight loss strategies, including lifestyle changes, medications, and surgery, are advised for individuals with obesity.
- For patients with clinical cardiovascular disease, medications such as sodium-glucose cotransporter 2 (SGLT2) inhibitors or glucagon-like peptide 1 (GLP-1) receptor agonists with proven cardiovascular benefits are recommended.
- SGLT2 inhibitors are specifically recommended for patients with chronic kidney disease or clinical heart failure alongside atherosclerotic cardiovascular disease.
- GLP-1 receptor agonists are suggested as the preferred first injectable medication for managing type 2 diabetes.
AI simplified